Impact of COVID-19 in patients on active melanoma therapy and with history of melanoma.

Johnson DB, Atkins MB, Hennessy C, Wise-Draper T, Heilman H, Awosika J, Bakouny Z, Labaki C, Saliby RM, Hwang C, Singh SRK, Balanchivadze N, Friese CR, Fecher LA, Yoon JJ, Hayes-Lattin B, Bilen MA, Castellano CA, Lyman GH, Tachiki L, Shah SA, Glover MJ, Flora DB, Wulff-Burchfield E, Kasi A, Abbasi SH, Farmakiotis D, Viera K, Klein EJ, Weissman LB, Jani C, Puc M, Fahey CC, Reuben DY, Mishra S, Beeghly-Fadiel A, French B, Warner JL, COVID-19 and Cancer Consortium

Open source

DOI
10.1186/s12885-023-10708-6
Published
2023 Mar 23
Container
BMC cancer
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12885-023-10708-6,
  title = {Impact of COVID-19 in patients on active melanoma therapy and with history of melanoma.},
  author = {Johnson DB and Atkins MB and Hennessy C and Wise-Draper T and Heilman H and Awosika J and Bakouny Z and Labaki C and Saliby RM and Hwang C and Singh SRK and Balanchivadze N and Friese CR and Fecher LA and Yoon JJ and Hayes-Lattin B and Bilen MA and Castellano CA and Lyman GH and Tachiki L and Shah SA and Glover MJ and Flora DB and Wulff-Burchfield E and Kasi A and Abbasi SH and Farmakiotis D and Viera K and Klein EJ and Weissman LB and Jani C and Puc M and Fahey CC and Reuben DY and Mishra S and Beeghly-Fadiel A and French B and Warner JL and COVID-19 and Cancer Consortium},
  year = {2023},
  journal = {BMC cancer},
  doi = {10.1186/s12885-023-10708-6},
  url = {https://doi.org/10.1186/s12885-023-10708-6}
}

RIS

TY  - JOUR
TI  - Impact of COVID-19 in patients on active melanoma therapy and with history of melanoma.
AU  - Johnson DB
AU  - Atkins MB
AU  - Hennessy C
AU  - Wise-Draper T
AU  - Heilman H
AU  - Awosika J
AU  - Bakouny Z
AU  - Labaki C
AU  - Saliby RM
AU  - Hwang C
AU  - Singh SRK
AU  - Balanchivadze N
AU  - Friese CR
AU  - Fecher LA
AU  - Yoon JJ
AU  - Hayes-Lattin B
AU  - Bilen MA
AU  - Castellano CA
AU  - Lyman GH
AU  - Tachiki L
AU  - Shah SA
AU  - Glover MJ
AU  - Flora DB
AU  - Wulff-Burchfield E
AU  - Kasi A
AU  - Abbasi SH
AU  - Farmakiotis D
AU  - Viera K
AU  - Klein EJ
AU  - Weissman LB
AU  - Jani C
AU  - Puc M
AU  - Fahey CC
AU  - Reuben DY
AU  - Mishra S
AU  - Beeghly-Fadiel A
AU  - French B
AU  - Warner JL
AU  - COVID-19 and Cancer Consortium
PY  - 2023
JO  - BMC cancer
DO  - 10.1186/s12885-023-10708-6
UR  - https://doi.org/10.1186/s12885-023-10708-6
ER  - 

APA

DB, J., MB, A., C, H., T, W., H, H., J, A., Z, B., C, L., RM, S., C, H., SRK, S., N, B., CR, F., LA, F., JJ, Y., B, H., MA, B., CA, C., GH, L., L, T., SA, S., MJ, G., DB, F., E, W., A, K., SH, A., D, F., K, V., EJ, K., LB, W., C, J., M, P., CC, F., DY, R., S, M., A, B., B, F., JL, W., & Consortium, C. A. C. (2023). Impact of COVID-19 in patients on active melanoma therapy and with history of melanoma.. BMC cancer. https://doi.org/10.1186/s12885-023-10708-6

Source records